Haemonetics Corporation

Haemonetics is THE Blood Management Company. Our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. Collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. Our Mission We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
Company Growth (employees)
Type
Public
HQ
Braintree, US
Founded
1971
Size (employees)
3,225 (est)
Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, US

Haemonetics Corporation Office Locations

Haemonetics Corporation has offices in Braintree, Beirut, Tijuana, Chiyoda and in 10 other locations
Braintree, US (HQ)
400 Wood Rd
Wenshan District, TW
2 Section 6, Roosevelt Rd
Bengaluru, IN
104 Epip Zone Whitefield Rd
Macquarie Park, AU
Level 2, Everglade Campus 82 Waterloo Rd
Vancouver, CA
1099 W 8th Ave
Edmonton, CA
500 Td Tower 10025 102 A Ave Nw
Show all (14)

Haemonetics Corporation Data and Metrics

Haemonetics Corporation Financial Metrics

Haemonetics Corporation's revenue was reported to be $227.8 m in Q3, 2016
USD

Net income (FY, 2017)

(26.3 m)

Market capitalization (25-Jul-2017)

2.1 b

Cash (01-Apr-2017)

139.6 m
Haemonetics Corporation's current market capitalization is $2.1 b.
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

938.5 m910.4 m908.8 m

Revenue growth, %

(3%)(0%)

Cost of goods sold

470.1 m476 m502.9 m

Gross profit

468.4 m434.4 m405.9 m

Gross profit Margin, %

50%48%45%

R&D expense

54.2 m54.2 m45 m

General and administrative expense

366 m337.2 m317.2 m

Operating expense total

449.9 m393.9 m449.9 m

EBIT

46.4 m40.5 m(43.9 m)

EBIT margin, %

5%4%(5%)

Net Income

35.1 m16.9 m(55.6 m)(26.3 m)
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

213.4 m219.7 m233.4 m210 m220.3 m227.8 m

Cost of goods sold

110.9 m114.4 m124.5 m118.9 m116 m126.8 m

Gross profit

102.5 m105.3 m108.9 m91.1 m104.2 m101.1 m

Gross profit Margin, %

48%48%47%43%47%44%

R&D expense

11.3 m11.6 m10.9 m11.4 m8.3 m8.5 m

General and administrative expense

87.6 m74.6 m78.9 m87.5 m71.1 m71 m

Operating expense total

98.9 m86.1 m89.9 m98.9 m79.5 m79.4 m

EBIT

3.6 m19.2 m(61.2 m)(7.9 m)24.8 m21.2 m

EBIT margin, %

2%9%(26%)(4%)11%9%

Pre tax profit

1.6 m16.6 m(10.1 m)22.8 m

Income tax expense

1.9 m3.7 m(3.9 m)288 k3 m3.5 m

Net Income

(3.6 m)3.8 m19.8 m(267 k)12.6 m(46.8 m)(10.3 m)9.5 m24.9 m
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

192.5 m160.7 m115.1 m139.6 m

Accounts Receivable

319.2 m

Inventories

54.1 m40.1 m28.8 m176.9 m

Current Assets

623 m570.3 m488.1 m510 m

PP&E

271.4 m321.9 m337.6 m323.9 m

Goodwill

336.8 m334.3 m267.8 m210.8 m

Total Assets

1.5 b1.5 b1.3 b1.2 b

Accounts Payable

53.6 m48.4 m39.7 m43 m

Total Debt

437.7 m427.9 m408 m

Current Liabilities

216.9 m189.1 m185.6 m211.2 m

Additional Paid-in Capital

402.6 m427 m439.9 m482 m

Retained Earnings

433.3 m420.4 m316.2 m289.9 m

Total Equity

837.9 m826.1 m721.6 m739.6 m

Debt to Equity Ratio

0.5 x0.5 x0.6 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x

Financial Leverage

1.8 x1.8 x1.8 x1.7 x
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

139.9 m130 m125.2 m112.2 m100.2 m105.2 m118.2 m138.9 m129.6 m

Inventories

207.5 m209.4 m212.5 m211.1 m207.6 m203.9 m189.4 m194.5 m188.5 m

Current Assets

569.3 m557 m549.8 m508.4 m500.7 m501.4 m489.6 m512.4 m496.6 m

PP&E

328.2 m332.8 m339.7 m339.8 m336 m

Goodwill

337.2 m336.3 m335 m334.2 m333.6 m266.9 m268.6 m268.5 m267.3 m

Total Assets

1.5 b1.5 b1.5 b1.4 b1.4 b1.3 b1.3 b1.3 b1.3 b

Accounts Payable

55.2 m44.2 m46.8 m42.2 m42.1 m39.6 m36.8 m42 m48.8 m

Current Liabilities

165.9 m165.1 m164.3 m169.8 m188.1 m175.3 m199 m198.7 m216.2 m

Additional Paid-in Capital

404.7 m408.9 m417.4 m427.9 m430.5 m435.5 m445.1 m459.7 m468.3 m

Retained Earnings

409.3 m411.2 m423.6 m387.3 m384.4 m324.9 m305.8 m325.7 m341.1 m

Total Equity

791.6 m776.9 m719.6 m715.6 m749.1 m770.9 m

Financial Leverage

1.8 x1.8 x1.9 x1.8 x1.8 x1.7 x
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

35.1 m16.9 m(55.6 m)(26.3 m)

Depreciation and Amortization

81.7 m86.1 m89.9 m89.7 m

Accounts Receivable

6.1 m8.4 m(10.3 m)3.2 m

Inventories

(13 m)(17 m)11.9 m(1.6 m)

Accounts Payable

477 k2 m(30.2 m)21.1 m

Cash From Operating Activities

139.5 m127.2 m121.9 m159.7 m

Capital Expenditures

(73.6 m)(122.2 m)(102.4 m)(76.1 m)

Cash From Investing Activities

(105.8 m)(121.8 m)(104.8 m)(73.3 m)

Long-term Borrowings

(37.1 m)(8.5 m)(21.3 m)

Cash From Financing Activities

(20.7 m)(33.2 m)(62.6 m)(60.4 m)

Interest Paid

8.9 m8.5 m8.5 m7.9 m

Income Taxes Paid

1.5 m11.2 m7.8 m7 m

Free Cash Flow

65.9 m5 m19.5 m83.6 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(3.6 m)3.8 m19.8 m(267 k)12.6 m(46.8 m)(10.3 m)9.5 m24.9 m

Depreciation and Amortization

20.5 m41.6 m63.9 m22.3 m45 m67.7 m22.5 m45.3 m67.5 m

Accounts Receivable

7.9 m10.1 m6.8 m3.9 m

Inventories

(9.6 m)(13.2 m)(17.9 m)(718 k)2.5 m6.3 m(3.7 m)(12.7 m)(14 m)

Accounts Payable

(5.3 m)(25.2 m)(27.1 m)(40 m)8.3 m6.2 m20.3 m

Cash From Operating Activities

13.7 m45 m71.9 m9.3 m36.8 m68.6 m30.7 m70 m125.2 m

Capital Expenditures

(50.1 m)(73.9 m)(22.5 m)(41.6 m)(60.5 m)

Cash From Investing Activities

(37 m)(70.5 m)(100.1 m)(27.1 m)(52.8 m)(76.5 m)(22.4 m)(41.4 m)(58.7 m)

Cash From Financing Activities

(28.8 m)(35.5 m)(35.7 m)(29.8 m)(44 m)(47 m)(5 m)(4.6 m)(50 m)

Interest Paid

2 m4.2 m6.3 m2.1 m4.2 m6.2 m2.1 m4.1 m6.1 m

Income Taxes Paid

2.1 m8.4 m10.7 m1.6 m4.7 m5.9 m1.5 m3.9 m5.7 m

Free Cash Flow

(13.4 m)(5.3 m)8.2 m28.3 m64.6 m
Y, 2017

Financial Leverage

1.7 x

Haemonetics Corporation Operating Metrics

Haemonetics Corporation's Facilities was reported to be 8 in FY, 2016
FY, 2016

Facilities

8

Haemonetics Corporation Market Value History

Haemonetics Corporation Revenue Breakdown

Haemonetics Corporation Median Salaries

Source: 21 public H-1B filings from Haemonetics Corporation

Haemonetics Corporation Online and Social Media Presence

Haemonetics Corporation Company Life and Culture

You may also be interested in